This site uses cookies to improve your browsing experience. By continuing to browse this site you are agreeing to our use of cookies. For further information, please refer to Privacy Policy.
Shine-On BioMedical
  • LANGUAGE
    • 繁體中文
    • English
  • ABOUT
    • Overview
    • Milestone
    • Mission
    • Organization
    • Management and consulting team
  • Core Technologies
    • Targeted exosome for drug delivery
    • Trispecific T cell engager antibody
  • R&D Pipeline
    • Targeted exosome for drug delivery
      • SOB100: HLA-G targeted exosome (αHLA-G exo)
      • SOB101: HLA-G targeted exosomal doxorubicin
      • SOB102: HLA-G targeted exosomal microRNA
      • SOB201: Genetically engineered stem cell-derived exosomes
    • Trispecific T cell engager antibody
      • SOA101: Nanobody-based trispecific antibody T cell engager (Nb-TriTE)
      • SOA201: EphA10-trispecific immune cell engager antibody
    • Exosome-derived products
      • SOC101&SOC102
    • Products Pipeline
  • News
  • Links
    • 政府機構
    • 學術機構
    • 產業新知
  • Investor Zone
  • Sustainable development CSR
    • Sustainable development CSR
    • Ethics compliance and whistleblower protection
  • Stakeholders Area
  • Contact
  • Disclaimer
  • Terms
  • Privacy

Links

  1. HOME
  2. Links
Links
  • 政府機構
  • 學術機構
  • 產業新知
  1. 政府機構
  • TFDA-衛生福利部食品藥物管理署

    TFDA-衛生福利部食品藥物管理署
  • CDE 財團法人醫藥品查驗中心

    CDE 財團法人醫藥品查驗中心
  • FDA - 美國食品藥物管理局

    FDA - 美國食品藥物管理局

04-2327-2888

E-mail : service@shineon-bio.com

Rm. B, 10F., No. 573, Sec. 2, Taiwan Blvd., West Dist., Taichung City 403020, Taiwan

NAVIGATION
  • ABOUT
  • Core Technologies
  • R&D Pipeline
  • News
  • Links
  • Investor Zone
  • Sustainable development CSR
  • Stakeholders Area
  • Contact
  • Disclaimer
  • Terms
  • Privacy
  • HOME
Copyright © 2024 - Shine-On BioMedical Web design : Newscan
TOP
LANGUAGE
  • 繁體中文
  • English
  • ABOUT
    • Overview
    • Milestone
    • Mission
    • Organization
    • Management and consulting team
  • Core Technologies
    • Targeted exosome for drug delivery
    • Trispecific T cell engager antibody
  • R&D Pipeline
    • Targeted exosome for drug delivery
      • SOB100: HLA-G targeted exosome (αHLA-G exo)
      • SOB101: HLA-G targeted exosomal doxorubicin
      • SOB102: HLA-G targeted exosomal microRNA
      • SOB201: Genetically engineered stem cell-derived exosomes
    • Trispecific T cell engager antibody
      • SOA101: Nanobody-based trispecific antibody T cell engager (Nb-TriTE)
      • SOA201: EphA10-trispecific immune cell engager antibody
    • Exosome-derived products
      • SOC101&SOC102
    • Products Pipeline
  • News
  • Links
    • 政府機構
    • 學術機構
    • 產業新知
  • Investor Zone
  • Sustainable development CSR
    • Sustainable development CSR
    • Ethics compliance and whistleblower protection
  • Stakeholders Area
  • Contact
  • Disclaimer
  • Terms
  • Privacy